DR.Paulien van Acker, Nefrologie SRL
DR.Paulien van Acker, Nefrologie reported total assets of 277,920 € at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Jul 2026).
The score of DR.Paulien van Acker, Nefrologie shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +36 % Total assets +301 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
DR.Paulien van Acker, Nefrologie's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jul 2026
- Year ended 31 Dec 2024filed on 25 Jun 2025
- Year ended 31 Dec 2023filed on 13 Aug 2024
- Year ended 31 Dec 2022filed on 29 Aug 2023
DR.Paulien van Acker, Nefrologie's financial analysis
- Solvency30.9%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of DR.Paulien van Acker, Nefrologie
1 active director(s) in the register.
DR.Paulien van Acker, Nefrologie's shareholders and holdings →DR.Paulien van Acker, Nefrologie's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0780.524.158
- VAT number
- BE0780524158
- Peppol
- Registered · 0208:0780524158 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 17 Jan 2022
- Registered office
- 9052 Ghent
- Latest accounts
- 2025 · filed on 29 Jul 2026
- Activity
- Medical specialists activities (NACE 86220)
DR.Paulien van Acker, Nefrologie (SRL) has been based in Ghent since 2022, active in: medical specialists activities. For 2025, it reports a net profit of 218,015 € and equity of 85,803 €; its revenue is not published. Its solvency stands at 30.9%, below the median of its sector (72.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to DR.Paulien van Acker, Nefrologie
Companies in the same business, of comparable size and area, outside its group.
- DL & P Rental and operating of own or leased real estate Merelbeke-Melle · balance sheet 278,014 €
- De Paenhoeve Manufacture of basic pharmaceutical products Hechtel-Eksel · balance sheet 277,823 €
- Alnisa Market research and public opinion polling Zonnebeke · balance sheet 278,039 €
- Wimar Schoten · balance sheet 277,810 €
- Torg SC SPRL Namur · balance sheet 277,789 €
- Immo Haas Büllingen · balance sheet 277,703 €
- Keyinvest Renting RL Huy · balance sheet 278,144 €
Frequently asked questions about DR.Paulien van Acker, Nefrologie
What is the revenue of DR.Paulien van Acker, Nefrologie?
DR.Paulien van Acker, Nefrologie files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of DR.Paulien van Acker, Nefrologie?
In Belgium, the VAT number is the company number prefixed with BE: BE0780524158 for DR.Paulien van Acker, Nefrologie, if the company is VAT-registered. Its company number (CBE) is 0780.524.158.
Where is the registered office of DR.Paulien van Acker, Nefrologie?
According to the CBE register, the registered office of DR.Paulien van Acker, Nefrologie is in 9052 Ghent.
What is the equity of DR.Paulien van Acker, Nefrologie?
At the close of the 2025 financial year, the equity of DR.Paulien van Acker, Nefrologie amounts to 85,803 €, a solvency of 30.9% of total assets.
Who manages DR.Paulien van Acker, Nefrologie?
The register lists 1 active mandates at DR.Paulien van Acker, Nefrologie. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of DR.Paulien van Acker, Nefrologie
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →